These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9724006)
1. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis. Tian WZ; Navikas V; Matusevicius D; Söderström M; Fredrikson S; Hedlund G; Link H Acta Neurol Scand; 1998 Aug; 98(2):94-101. PubMed ID: 9724006 [TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782 [TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis. Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis. Link J; He B; Navikas V; Palasik W; Fredrikson S; Söderström M; Link H J Neuroimmunol; 1995 Apr; 58(1):21-35. PubMed ID: 7537278 [TBL] [Abstract][Full Text] [Related]
5. Linomide, an immunomodulator that inhibits Th1 cytokine gene expression. Arad G; Katzenellenbogen M; Levy R; Slavin S; Kaempfer R Int Immunol; 1996 Oct; 8(10):1603-7. PubMed ID: 8921440 [TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. Matusevicius D; Navikas V; Söderström M; Xiao BG; Haglund M; Fredrikson S; Link H J Neuroimmunol; 1996 May; 66(1-2):115-23. PubMed ID: 8964905 [TBL] [Abstract][Full Text] [Related]
7. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Navikas V; He B; Link J; Haglund M; Söderström M; Fredrikson S; Ljungdahl A ; Höjeberg J; Qiao J; Olsson T; Link H Brain; 1996 Feb; 119 ( Pt 1)():213-23. PubMed ID: 8624683 [TBL] [Abstract][Full Text] [Related]
8. Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines. Diab A; Michael L; Wahren B; Deng GM; Björk J; Hedlund G; Zhu J J Neuroimmunol; 1998 May; 85(2):146-54. PubMed ID: 9630163 [TBL] [Abstract][Full Text] [Related]
9. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses. Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420 [TBL] [Abstract][Full Text] [Related]
10. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes. Karussis D; Abramsky O; Rosenthal Y; Mizrachi-Koll R; Ovadia H Immunol Lett; 1999 Apr; 67(3):203-8. PubMed ID: 10369127 [TBL] [Abstract][Full Text] [Related]
11. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis. Rohowsky-Kochan C; Molinaro D; Cook SD Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850 [TBL] [Abstract][Full Text] [Related]
12. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Navikas V; Link J; Palasik W; Söderström M; Fredrikson S; Olsson T; Link H Scand J Immunol; 1995 Feb; 41(2):171-8. PubMed ID: 7532318 [TBL] [Abstract][Full Text] [Related]
13. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. Zhang GX; Yu LY; Shi FD; Xiao BG; Björk J; Hedlund G; Link H J Neuroimmunol; 1997 Mar; 73(1-2):175-82. PubMed ID: 9058774 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis. Matusevicius D; Kivisäkk P; Navikas V; Söderström M; Fredrikson S; Link H Scand J Immunol; 1998 Jun; 47(6):582-90. PubMed ID: 9652827 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776 [TBL] [Abstract][Full Text] [Related]
17. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission. Hollifield RD; Harbige LS; Pham-Dinh D; Sharief MK Autoimmunity; 2003 May; 36(3):133-41. PubMed ID: 12911279 [TBL] [Abstract][Full Text] [Related]
18. Influence of IFN-beta1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis. Matusevicius D; Kivisakk P; Navikas V; Tian W; Soderstrom M; Fredrikson S; Link H Eur J Neurol; 1998 May; 5(3):265-275. PubMed ID: 10210841 [TBL] [Abstract][Full Text] [Related]
19. Linomide abolishes leukocyte adhesion and extravascular recruitment induced by tumor necrosis factor alpha in vivo. Zhang XW; Hedlund G; Borgström P; Arfors KE; Thorlacius H J Leukoc Biol; 2000 Nov; 68(5):621-6. PubMed ID: 11073099 [TBL] [Abstract][Full Text] [Related]
20. Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice. del Real G; Llorente M; Boscá L; Hortelano S; Serrano A; Lucas P; Gómez L; Torán JL; Redondo C; Martínez C AIDS; 1998 May; 12(8):865-72. PubMed ID: 9631139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]